3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

This study is currently recruiting participants.

Verified May 2013 by Memorial Sloan-Kettering Cancer Center

Sponsor:

Collaborators:

Janssen Pharmaceuticals

OHSU Knight Cancer Institute

Cancer Institute of New Jersey

NorthShore University HealthSystem Research Institute

Duke University

Feinberg School of Medicine, Northwestern University

Sidney Kimmel Comprehensive Cancer Center

University of North Carolina

Wayne State University

Information provided by (Responsible Party):

Memorial Sloan-Kettering Cancer Center

ClinicalTrials.gov Identifier:

NCT01751451

First received: December 14, 2012

Last updated: May 21, 2013

Last verified: May 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	October 2014
Estimated Primary Completion Date:	October 2014 (Final data collection date for primary outcome measure)